In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Genvec Inc. (NASDAQ:GNVC) reported that Mmcap International Inc. Spc has picked up 114,827 of common stock as of 2017-02-16.

The acquisition brings the aggregate amount owned by Mmcap International Inc. Spc to a total of 114,827 representing a 5.05% stake in the company.

For those not familiar with the company, GenVec, Inc. (GenVec) is a clinical-stage biopharmaceutical company, engaged in the development of therapeutics and vaccines. The Company designs, tests and manufactures adenoviral-based product candidates. The Company’s development programs address therapeutic areas, such as hearing loss and balance disorders, as well as vaccines against infectious diseases, including respiratory syncytial virus (RSV), herpes simplex virus (HSV), Enterovirus D68 (EV-D68) and malaria. In the area of animal health, it is developing vaccines against foot-and-mouth disease (FMD). The Company develops and commercializes its product candidates through collaborations. The Company’s lead product candidate is CGF166. The Company’s vaccine candidates include preventative vaccines against RSV and malaria, and a therapeutic vaccine for HSV. The Company is developing vaccine and anti-viral candidates for the prevention and containment of FMD outbreaks.

A glance at Genvec Inc. (NASDAQ:GNVC)’s key stats reveals a current market capitalization of 16.66 million based on 2.27 million shares outstanding and a price at last close of $7.15 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2016-09-16, Swirsky picked up 10,000 at a purchase price of $0.50. This brings their total holding to 252,500 as of the date of the filing.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Genvec Inc. (NASDAQ:GNVC) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.